Noam Kirson

Managing Principal
Noam Kirson



Ph.D., economics, Harvard University; B.A., philosophy, political science, and economics, Hebrew University

Summary of Experience

Dr. Kirson is an applied health economist with extensive experience in health economics and outcomes research (HEOR), strategy and market access, and complex litigation matters. He specializes in the application of advanced statistical methods to the analysis of a variety of real-world and clinical data, as well as the development of advanced modeling tools. He has worked closely with many different stakeholders in the health care industry, including biopharmaceutical and device manufacturers, payers, government agencies, leading law firms, and academic experts. Dr. Kirson has managed numerous HEOR and strategy projects, including design of outcomes-based contracts, analysis of pharmaceutical pricing issues, burden-of-illness studies, comparative-effectiveness research, cost-effectiveness evaluations, and budget impact assessments. His work has resulted in numerous conference presentations and peer-reviewed publications, including in Health Affairs, Alzheimer's & Dementia, Diabetes Care, Critical Care Medicine, theJournal of Clinical Psychiatry, and various pharmacoeconomic journals. In the regulatory context, Dr. Kirson has supported a successful 510(k) pre-market submission to the US Food and Drug Administration (FDA) on behalf of a medical device manufacturer, including presentation of statistical analyses to an FDA advisory panel. His litigation case work has included evaluation of antitrust matters in the health care sector, as well as assessment of issues pertaining to the False Claims Act. Dr. Kirson is a member of the editorial board of Pharmacoeconomics Open and a member of the board of the ISPOR Boston Regional Chapter. He has also published in non-academic outlets, such as Health Affairs Blog, STAT, and Law360.

Selected Publishing